Kazakhstan kicks off thyroid cancer drug production
NUR-SULTAN. KAZINFORM On June 22 the Institute of Nuclear Physics produced the first commercial batch of a radiopharmaceutical agent, Sodium Iodide I 131, to treat thyroid disorders, as well as thyroid cancer, the Energy Ministry’s press service reports.
On June 24 the drug was delivered to treat the first patients at the Nuclear Medicine and Oncology Centre in Semey.
The Institute plans to develop new drugs to diagnose and treat various diseases using a wide range of radiopharmaceutical agents to improve people’s health and lives on the ground of the latest developments in nuclear medicine.
- Kazakh Head of State meets with EBRD President Odile Renaud-Basso
- Tokayev addresses 9th Forum of Machine Builders of Kazakhstan, expresses State's support to sector
- Humanitarian sphere has reached a new level - Kazakh Secretary of State
- 827,000 fully vaccinated against COVID-19 in Almaty
- Above 100 kids treated for coronavirus in Almaty
- Australia seeks COVID vaccine approval for children as young as five
- Speeches of the President of the Republic of Kazakhstan
- President's Address to the Nation
- Development of the President's Message
- Foreign Mass Media about Kazakhstan
- World and Crisis